NICKOLAS MILEOS: Open Payments
NPI 1174039101 · NEW PORT RICHEY, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$479 in 24 payments from 11 companies in 2025. Trend: 2023 $1,207 · 2024 $1,519 · 2025 $479
Food & beverage: $479
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $94 |
| PFIZER INC. | 4 | $87 |
| Amgen Inc. | 3 | $61 |
| ABBVIE INC. | 3 | $53 |
| Merck Sharp & Dohme LLC | 2 | $41 |
| Astellas Pharma US Inc | 2 | $34 |
| Kowa Pharmaceuticals America, Inc. | 2 | $29 |
| Lilly USA, LLC | 1 | $24 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $22 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
Products named: NURTEC ODT, Wegovy, Ozempic, GARDASIL 9, OTEZLA, Veozah, ZORYVE, KRYSTEXXA.
Industry payments across FL — which companies pay providers there.
